Multicentric Study About Treatment of High Grade Peripheral T Cell Lymphoma in Adults. LTP Study Comparison Between VIP ABVD Versus CHOP
Induction therapy:
ARM 1: 6 Chemotherapy courses = 3 VIP alternated with 3 ABVD ARM 2: 8 Chemotherapy courses =
CHOP every 21 days
Consolidation therapy:
For all patients if CR = radiotherapy 40GY / 5X1,8 GY per week
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Comparison between EFS rate of CHOP/21 versus VIP-rABVD in newly diagnosed PTCL.
2 years
Yes
Remy GRESSIN, MD MS
Principal Investigator
CHU Grenoble GOELAMS
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
LTP 95
NCT00970385
January 1995
September 2008
Name | Location |
---|